Raman Chitkara - 02 Jun 2026 Form 4 Insider Report for Arteris, Inc. (AIP)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
04 Jun 2026, 18:59:33 UTC
Prior SEC filing
02 Jun 2026
Next SEC filing
15 Jun 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Paul Alpern, as Attorney-in-Fact for Chitkara Raman

Key filing fact

Raman Chitkara filed Form 4 for Arteris, Inc. (AIP) on 04 Jun 2026.

Key facts

  • This page summarizes Raman Chitkara's Form 4 filing for Arteris, Inc. (AIP).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 04 Jun 2026, 18:59.

Change

  • Previous filing in this sequence was filed on 02 Jun 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001748459 Primary reporting owner

Chitkara Raman

Relationship
Director
Address
C/O ARTERIS, INC., 900 E. HAMILTON AVE., SUITE 300, CAMPBELL
Signature
/s/ Paul Alpern, as Attorney-in-Fact for Chitkara Raman
Signature date
04 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AIP transaction

Common Stock

Award

Transaction value
Shares
+4,703
Change %
+3.3%
Price
$0.000000*
Shares after
147,570
Date
02 Jun 2026
Ownership
Direct
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Includes 4,703 restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the earlier of (i) the first anniversary of the grant date and (ii) immediately before the annual meeting of the Issuer's stockholders following the grant date, subject to the reporting person continuing to provide services to Issuer's Board through such vesting date. The RSUs have no expiration date. This grant of restricted stock was made on June 2, 2026, based on the average trading price of Arteris, Inc. common stock for the period from April 21, 2026 through June 2, 2026, which was $31.89.

Footnote F2

The Reporting Person elected to defer the receipt of shares.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .